Xcellerex, Inc. Secures $31,000,000 Series C Funding Round

  • Feed Type
  • Date
  • Company Name
    Xcellerex, Inc.
  • Mailing Address
    170 Locke Drive Marlborough, MA 01752
  • Company Description
    Xcellerex is revolutionizing the way biomolecules are developed, manufactured and commercialized.

    Xcellerex is built around a unique biomanufacturing platform that features the innovative application of single-use component technology.

  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    “The financing will enable us to continue the development and commercialization of the FlexFactory model, initiate development of proprietary biomolecules using the FlexFactory and grow our bioreactor business,” said Joseph S. Zakrzewski, Chief Executive Officer of Xcellerex.
  • M&A Terms
  • Venture Investor
    VantagePoint Venture Partners
  • Venture Investor
    Kleiner Perkins Caufield & Byers

Trending on Xconomy